Featured Research

from universities, journals, and other organizations

Reduction in HPV in young women in England following national immunization program

Date:
April 14, 2014
Source:
Society for General Microbiology
Summary:
A reduction in two High Risk human papillomavirus types in sexually-active young women in England has been seen, following the introduction of a national immunization program. "The data provide reassurance that the high efficacy against HPV infection in women reported in clinical trials can be effectively realized in practice, and in a program achieving high coverage amongst young females. These data adds to our confidence that the HPV immunization program will achieve its aim of reducing cervical cancer," researchers concluded.

Each year around 2,000-2,500 women are diagnosed with cervical cancer in England, the most common cancer in women under 35. Infection with high-risk human papillomavirus (HR HPV) types 16 and 18 is responsible for around 70-80% of cervical cancers. A study conducted by Public Health England and presented at the Society for General Microbiology's Annual Conference shows a reduction in these two HR HPV types -- which are included in the HPV vaccines used -- in sexually active young women in England.

Related Articles


Between 2010 and 2012, over 4000 samples were collected from young women receiving a chlamydia screen as part of the National Chlamydia Screening program in England. Prior to the HPV immunization program introduction, a survey showed around 1 in 5 sexually active women aged 16 to 18 were infected with at least one of the two HPV types included in vaccines. A similar survey conducted following the introduction of the program showed the prevalence had dropped to 1 in 15 young women.

Post-immunization prevalence of HPV types 16 and 18 infection was lowest among women aged 16 to 18 year old, the age group with the highest vaccination coverage. Prior to the immunization program, this age group was shown to have the highest prevalence of infection.

David Mesher, Public Health England, presenting the work at the conference, said: "This study provides an early indication that the national HPV immunization program is successfully reducing vaccine-type HPV infections in sexually active young women in England, and also suggests herd-immunity may be benefiting non-vaccinated young women and men.

"The data provide reassurance that the high efficacy against HPV infection in women reported in clinical trials can be effectively realized in practice, and in a program achieving high coverage amongst young females. These data adds to our confidence that the HPV immunization program will achieve its aim of reducing cervical cancer."


Story Source:

The above story is based on materials provided by Society for General Microbiology. Note: Materials may be edited for content and length.


Cite This Page:

Society for General Microbiology. "Reduction in HPV in young women in England following national immunization program." ScienceDaily. ScienceDaily, 14 April 2014. <www.sciencedaily.com/releases/2014/04/140414092123.htm>.
Society for General Microbiology. (2014, April 14). Reduction in HPV in young women in England following national immunization program. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2014/04/140414092123.htm
Society for General Microbiology. "Reduction in HPV in young women in England following national immunization program." ScienceDaily. www.sciencedaily.com/releases/2014/04/140414092123.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins